Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater: Commentary

Journal of Urology

Volumn 175, Issue 1, 2006, Pages 220-221

  Wilt, Timothy J ^a  

^a Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXAZOSIN; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; ECHOGRAPHY; HUMAN; NOTE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOLUMETRY;

EID: 29144443622     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00295-8     Document Type: Note

References (3)

1. Kaplan SA, McConnell JD, Roehrborn CG et al. Combination Therapy with Doxazosin and Finasteride Led to a Significantly Greater Reduction in the Risk of Clinical Progression of BPH Compared to Either Drug Alone in LUTS Patients with a Baseline Total Prostate Volume of < 25 mL.
2. J.H. Ware The National Emphysema Treatment Trial - low strong is the evidence? N Engl J Med 348 2003 2055
3. E.D. Vaughan Jr Medical management of benign prostatic hyperplasia - are two drugs better than one? N Engl J Med 349 2003 2449